COMMUNIQUÉS West-GlobeNewswire

Augmedix Delivers 40% Revenue Growth for First Quarter of 2024
13/05/2024
SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results for the three months ended March 31, 2024. “ [...]
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
13/05/2024
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has entered into a [...]
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
13/05/2024
New Drug Application for DFD-29 to treat rosacea accepted for U.S. FDA review; PDUFA goal date of November 4, 2024 Total revenues for the first quarter ended March 31, 2024 were $13.0 million, a 7% increase from the $12 [...]
Voyager Therapeutics Reports First Quarter 2024 Financial and Operating Results
13/05/2024
- Company announces clearance of IND application with FDA for anti-tau antibody VY-TAU01 for the treatment of Alzheimer’s disease; expect to begin single ascending dose trial in the coming weeks - - Development [...]
Cara Therapeutics Reports First Quarter 2024 Financial Results
13/05/2024
Topline efficacy and safety results from KOURAGE 1 Part A portion of notalgia paresthetica (NP) pivotal program now expected by the end of 2Q24 STAMFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. ( [...]
Aprea Therapeutics to Attend the 2024 RBC Capital Markets Global Healthcare Conference
13/05/2024
DOYLESTOWN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage biopharmaceutical company focused on precision oncology through synthetic lethality [...]
Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
13/05/2024
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that Marc Elia, [...]
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
13/05/2024
Positive results from Phase 1 norovirus study in lactating mothers indicate the potential of Vaxart’s oral pill vaccine candidate to protect or reduce the effect of the disease in infants Expects to initiate Phase 2b [...]
Teknova Reports First Quarter 2024 Financial Results
13/05/2024
First quarter 2024 total revenue was $9.3 million, up 2% from prior year Launch of Build-Tek™ Custom Configurator Company reaffirms 2024 revenue guidance of $35-38 million HOLLISTER, Calif., May 13, 2024 (GLOBE NEWSWIRE [...]
Assure & Danam to Host Corporate Update Call & Webcast
13/05/2024
DENVER, May 13, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that [...]
Allogene Therapeutics Reports First Quarter 2024 Financial Results and Business Update
13/05/2024
Cemacabtagene Ansegedleucel (Cema-Cel) Expanded CD19 Oncology Rights to Include all EU Member States and the United Kingdom, Reinforcing Company’s Conviction in the Unique Opportunity in Large B Cell Lymphoma (LBCL) and [...]
AVITA Medical Reports First Quarter Financial Results
13/05/2024
VALENCIA, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]
Akoya Biosciences Reports First Quarter 2024 Financial Results
13/05/2024
MARLBOROUGH, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company ® , today announced its financial results for the first quarter ending March 31, 2024. [...]
Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
13/05/2024
CHARLOTTESVILLE, Va., May 13, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta [...]
A Pint for Kim Blood Drive Breaks State Record Fifth Year in a Row with More than 700 Donors Showing Up to Give Blood
13/05/2024
National grassroots movement has secured tens of thousands of pints of blood, all in honor of a mom who lost her eight-year battle with rare cancer NAPERVILLE, Ill., May 13, 2024 (GLOBE NEWSWIRE) -- A Pint For Kim , a [...]
Claritas HealthTech Further Expands Global Presence with Entry into Brazil Focusing on its Solutions in Nuclear Medicine
13/05/2024
LONDON and NEW YORK and SAO PAULO, Brazil, May 13, 2024 (GLOBE NEWSWIRE) -- Claritas HealthTech (“Claritas”) , a healthcare technology company specializing in advanced medical image enhancement, reconstruction, and AI [...]
SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
13/05/2024
Pain Relief Resulted in Improved Objective Measure of Walking Ability at End of Treatment CLEVELAND, May 13, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics announced the publication of a multicenter double-blind randomized, [...]
Spectrum Healthcare Resources awarded new 10-year contract to deliver health care for active duty and retired military personnel and families
13/05/2024
ST. LOUIS, May 13, 2024 (GLOBE NEWSWIRE) -- Spectrum Healthcare Resources (Spectrum), a long-standing, trusted partner of the U.S. Department of Defense Military Health System, announces that it was awarded a 10-year [...]
Fagron shareholders approve all voting items at AGM and EGM
13/05/2024
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 13 May 2024 – 7PM CET Fagron shareholders approve all voting items at AGM and EGM Fagron, the leading global player in pharmaceutical compounding, [...]

Pages